Pontifax Management 4 G.P. (2015) Ltd.

Insider Reports History

Location
Herzliya Pituach, Israel
Signature
Pontifax Management 4 G.P. (2015) Ltd., By: /s/ Tomer Kariv, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pontifax Management 4 G.P. (2015) Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eloxx Pharmaceuticals, Inc. 10%+ Owner Common Stock 616,592 $443,946 $0.7200 13 May 2021 By Pontifax Investment Fund
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 5,250 $83,055 $15.82 15 Oct 2025 By Ran Nussbaum
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 5,250 $83,055 $15.82 15 Oct 2025 By Tomer Kariv
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (Cayman) IV, L.P.
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (China) IV, L.P.
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (Israel) IV, L.P.
Keros Therapeutics, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax Late Stage Fund, L.P.
LB PHARMACEUTICALS INC 10%+ Owner Common Stock 1,411,681 12 Sep 2025 Indirect
LB PHARMACEUTICALS INC 10%+ Owner Series C Preferred Stock 0 12 Sep 2025 Indirect

Insider Reports Filed by Pontifax Management 4 G.P. (2015) Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 15 Oct 2025 4 $-84,975,125 4 10%+ Owner 17 Oct 2025, 17:53
LBRX LB PHARMACEUTICALS INC 12 Sep 2025 3 $15,000,000 4 10%+ Owner 16 Sep 2025, 16:15
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 10%+ Owner 11 Sep 2025, 11:05
KROS Keros Therapeutics, Inc. 29 Nov 2022 6 $-0.7176 4 10%+ Owner 30 Nov 2022, 15:42
ELOX Eloxx Pharmaceuticals, Inc. 13 May 2021 4 $7,999,999 4 10%+ Owner 17 May 2021, 07:03
KROS Keros Therapeutics, Inc. 07 Apr 2020 0 $0 3/A 10%+ Owner 30 Nov 2022, 15:37